PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 4191184-0 1968 [Physiologic reaction of the organism to dicoumarin therapy: incidence on prothrombin activity; statistical study]. Dicumarol 41-51 coagulation factor II, thrombin Homo sapiens 74-85 1699555-0 1990 Dicoumarol-induced 9-gamma-carboxyglutamic acid prothrombin: isolation and comparison with the 6-, 7-, 8-, and 10-gamma-carboxyglutamic acid isomers. Dicumarol 0-10 coagulation factor II, thrombin Homo sapiens 48-59 1699555-1 1990 The role of gamma-carboxyglutamic acid (Gla) in prothrombin function can be effectively evaluated by characterizing dicoumarol-induced, Gla-deficient prothrombin structural isomers. Dicumarol 116-126 coagulation factor II, thrombin Homo sapiens 48-59 1699555-1 1990 The role of gamma-carboxyglutamic acid (Gla) in prothrombin function can be effectively evaluated by characterizing dicoumarol-induced, Gla-deficient prothrombin structural isomers. Dicumarol 116-126 coagulation factor II, thrombin Homo sapiens 150-161 6168225-0 1981 Degradation of normal and dicoumarol-induced prothrombins with thrombin. Dicumarol 26-36 coagulation factor II, thrombin Homo sapiens 48-56 4119069-0 1973 Binding of Ca 2+ to normal and dicoumarol-induced prothrombin. Dicumarol 32-42 coagulation factor II, thrombin Homo sapiens 51-62 4120903-0 1972 Atypical prothrombin in purified preparations from dicoumarol-treated steers. Dicumarol 51-61 coagulation factor II, thrombin Homo sapiens 9-20 4109212-0 1971 Synthesis of an abnormal prothrombin in malnutrition and biliary obstruction and during dicumarol treatment. Dicumarol 88-97 coagulation factor II, thrombin Homo sapiens 25-36 4106764-0 1971 Effect of steroids, acetylsalicylic acid and bishydroxycoumarin on prothrombin time. Dicumarol 45-63 coagulation factor II, thrombin Homo sapiens 67-78 2465958-3 1988 In a group of 347 patients under dicoumarol therapy of different intensity and duration PIVKA was detected in BaSO4 adsorbed PPP only in samples where prothrombin level (Quick"s test) was lower than 50% of normal values. Dicumarol 33-43 coagulation factor II, thrombin Homo sapiens 151-162 6157217-0 1980 Protein M and the activation of dicoumarol induced atypical prothrombin. Dicumarol 32-42 coagulation factor II, thrombin Homo sapiens 60-71 53896-0 1975 Proceedings: Activation of dicoumarol-induced atypical prothrombin. Dicumarol 27-37 coagulation factor II, thrombin Homo sapiens 55-66 4138039-2 1974 Isolation of peptides containing prosthetic groups from normal prothrombin and the corresponding peptides from dicoumarol-induced prothrombin. Dicumarol 111-121 coagulation factor II, thrombin Homo sapiens 130-141 4126258-0 1973 A conformational study of normal and dicoumarol-induced prothrombin. Dicumarol 37-47 coagulation factor II, thrombin Homo sapiens 56-67 4121396-0 1973 The nature of the heterogeneity of prothrombin during dicoumarol therapy. Dicumarol 54-64 coagulation factor II, thrombin Homo sapiens 35-46 4178912-0 1968 Plasma prothrombin during treatment with Dicumarol. Dicumarol 41-50 coagulation factor II, thrombin Homo sapiens 7-18 4178913-0 1968 Plasma prothrombin during treatment with Dicumarol. Dicumarol 41-50 coagulation factor II, thrombin Homo sapiens 7-18 4181975-0 1966 [Change in the fibrinogen concentration in the blood following an intravenous injection of thrombin to dicoumarin-fed animals]. Dicumarol 103-113 coagulation factor II, thrombin Homo sapiens 91-99 13766979-0 1961 [The use of prothrombin determination with hirudin in the supervision of treatment with dicoumarol derivatives]. Dicumarol 88-98 coagulation factor II, thrombin Homo sapiens 12-23 13349502-0 1956 [Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy]. Dicumarol 128-137 coagulation factor II, thrombin Homo sapiens 44-55 13209750-0 1954 The control of dicumarol therapy in myocardial infarction by a simple blood prothrombin test. Dicumarol 15-24 coagulation factor II, thrombin Homo sapiens 76-87 13238066-0 1954 Prothrombin time longer than recalcification time; a paradoxical phenomenon in dicoumarol hypersensitivity. Dicumarol 79-89 coagulation factor II, thrombin Homo sapiens 0-11 13217722-0 1954 Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin. Dicumarol 11-20 coagulation factor II, thrombin Homo sapiens 100-111 13196956-0 1954 Comparison of two methods for determining prothrombin during dicumarol therapy. Dicumarol 61-70 coagulation factor II, thrombin Homo sapiens 42-53 13057268-0 1953 The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin. Dicumarol 26-35 coagulation factor II, thrombin Homo sapiens 101-112 14933315-0 1952 The action of dicumarol in the human being on plasma prothrombin time and total prothrombin time. Dicumarol 14-23 coagulation factor II, thrombin Homo sapiens 53-64 14933315-0 1952 The action of dicumarol in the human being on plasma prothrombin time and total prothrombin time. Dicumarol 14-23 coagulation factor II, thrombin Homo sapiens 80-91 14936621-0 1952 [Comparative studies on the effect of dicumarol and tromexan on prothrombin level, capillary resistance and capillary permeability]. Dicumarol 38-47 coagulation factor II, thrombin Homo sapiens 64-75 14950380-0 1952 The prothrombin level in patients on dicoumarol therapy; a simplified capillary technique. Dicumarol 37-47 coagulation factor II, thrombin Homo sapiens 4-15 14939638-0 1952 [Problems of prothrombin determination; comparative studies with the one- and two-phase method in the control of the dicoumarin medication]. Dicumarol 117-127 coagulation factor II, thrombin Homo sapiens 13-24 14051485-4 1963 Prothrombin activity levels returned to pretreatment values only after ten days following termination of coumarin or Dicumarol administration. Dicumarol 117-126 coagulation factor II, thrombin Homo sapiens 0-11 14854798-0 1951 A comparison between the effect of intravenously and orally administrated dicumarol on the plasma prothrombin levels in man. Dicumarol 74-83 coagulation factor II, thrombin Homo sapiens 98-109 14788260-0 1950 Observations on the synergistic effect of salicylate and dicoumarol of the depression of plasma prothrombin activity in humans. Dicumarol 57-67 coagulation factor II, thrombin Homo sapiens 96-107 14773979-0 1950 EFFECTS of dicumarol on prothrombin levels. Dicumarol 11-20 coagulation factor II, thrombin Homo sapiens 24-35 15432322-2 1950 Prothrombin as determined with the isolation technic, in patients receiving dicumarol. Dicumarol 76-85 coagulation factor II, thrombin Homo sapiens 0-11 18139386-0 1949 Dicumarol therapy controlled by the stabilized thrombin method for determination of prothrombin. Dicumarol 0-9 coagulation factor II, thrombin Homo sapiens 47-55 18139386-0 1949 Dicumarol therapy controlled by the stabilized thrombin method for determination of prothrombin. Dicumarol 0-9 coagulation factor II, thrombin Homo sapiens 84-95 16810826-0 1949 Estimation of Prothrombin in Dicoumarin Therapy. Dicumarol 29-39 coagulation factor II, thrombin Homo sapiens 14-25 18130447-0 1949 The nature of the prothrombin deficiency in dicoumarin plasma. Dicumarol 44-54 coagulation factor II, thrombin Homo sapiens 18-29 18935077-0 1948 Dicumarol poisoning and vitamin K deficiency in relation to Quick"s concept of the composition of prothrombin. Dicumarol 0-9 coagulation factor II, thrombin Homo sapiens 98-109 18865331-0 1948 Vitamin K for the balancing of prothrombin index in dicoumarin treatment. Dicumarol 52-62 coagulation factor II, thrombin Homo sapiens 31-42 20265749-0 1947 Variations in prothrombin and antithrombin following the administration of dicumarol. Dicumarol 75-84 coagulation factor II, thrombin Homo sapiens 14-25 20289826-0 1947 On the relation of calcium to the activation of prothrombin and its significance in dicumarol poisoning. Dicumarol 84-93 coagulation factor II, thrombin Homo sapiens 48-59 20989497-0 1946 Experimentally induced changes in the prothrombin level of the blood; prothrombin concentration of new-born pups of a mother given dicumarol before parturition. Dicumarol 131-140 coagulation factor II, thrombin Homo sapiens 38-49 20989497-0 1946 Experimentally induced changes in the prothrombin level of the blood; prothrombin concentration of new-born pups of a mother given dicumarol before parturition. Dicumarol 131-140 coagulation factor II, thrombin Homo sapiens 70-81 20322380-0 1942 The Effect of the Synthetic Haemorrhagic Agent, 3,3"-Methylenebis (4-Hydroxycoumarin), in Prolonging the Coagulation and Prothrombin Time in the Human Subject. Dicumarol 48-84 coagulation factor II, thrombin Homo sapiens 121-132 14869347-0 1951 The effect of dicoumarol on co-thromboplastin, a factor in blood concerned with the conversion of prothrombin to thrombin. Dicumarol 14-24 coagulation factor II, thrombin Homo sapiens 101-109